Document is current
Any future updates will be listed below
-
Authors
Peleman, Cédric
Hellemans, Stig
Veeckmans, Geraldine
Arras, Wout
Zheng, Hao
Koeken, Ine
Van San, Emily https://orcid.org/0000-0003-1429-1980
Hassannia, Behrouz
Walravens, Magali
Kayirangwa, Edissa
Beyene, Nateneal Tamerat
Van Herck, Mikhaïl Alfons
De Vos, Winnok Harald
Pintelon, Isabel
van Nassauw, Luc
Oosterlinck, Baptiste
Smet, Annemieke
Vits, Lieve
Dirinck, Eveline
Verrijken, An
De Man, Joris
Van Eyck, Annelies https://orcid.org/0000-0003-4722-969X
Kwanten, Wilhelmus Josephus https://orcid.org/0000-0001-9474-6695
Vonghia, Luisa
Driessen, Ann
Augustyns, Koen https://orcid.org/0000-0002-5203-4339
Toyokuni, Shinya https://orcid.org/0000-0002-5757-1109
De Winter, Benedicte https://orcid.org/0000-0003-0327-6304
Van Steenkiste, Christophe
Francque, Sven
Vanden Berghe, Tom https://orcid.org/0000-0002-1633-0974
-
Funding
Funding for this research was provided by:
Universiteit Antwerpen (FFB180348/36572)
Fonds Wetenschappelijk Onderzoek (1171121N, 1SH9524N, 1802154N)
- License Information
-
More Information
Article History
Received: 28 May 2024
Revised: 15 July 2024
Accepted: 17 July 2024
First Online: 26 July 2024
Competing interests
: TVB and KA own patents related to ferroptosis inhibitors (US9862678, WO2016075330, EP3218357, WO2019154795). All other authors declare that they have no financial or non-financial interests related to this manuscript. Please refer to the accompanying ICMJE disclosure forms for further details.
: Assessment of human data was approved by the Ethical Committee of Antwerp University Hospital. All animal experiments were ethically approved by the Ethical Committee of Animal Experimentation of the University of Antwerp and the Animals Ethics Committee of Ghent University.
